| Ytd | -95.21% | |
| 1y | -91.37% |
| Open | 0.14 | Prev Close | 0.15 | Low | 0.14 | High | 0.15 | Mkt Cap | 36.31M |
| Vol | 1.84M | Avg Vol | 14.64M | EPS | -0.79 | P/E | -0.20 | Forward P/E | -1.24 |
| Beta | 2.04 | Short Ratio | 6.29 | Inst. Own | 77.48% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 0.20 | 200-d Avg | 1.48 | 1yr Est | 7.61 |
GOSS News
SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (NASDAQ: GOSS) (the “Company” or “Gossamer”), a bioph
HC Wainwright & Co. analyst Patrick R. Trucchio maintains Gossamer Bio (NASDAQ:GOSS) with a B
Gossamer Bio, Inc. (NASDAQ:GOSS) (the "Company" or "Gossamer"), a biopharmaceutical
SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (NASDAQ: GOSS) (the “Company” or “Gossamer”), a bioph
SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (NASDAQ: GOSS) (the “Company” or “Gossamer”), a bioph
SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (NASDAQ: GOSS) (the “Company” or “Gossamer”), a bioph
[url="]Faruqi and Faruqi, LLP[/url], a leading national securities law firm, is investigating potent
NEW YORK--(BUSINESS WIRE)---- $GOSS #Bio--Faruqi & Faruqi, LLP, a leading national securities law fi
New York, New York--(Newsfile Corp. - June 1, 2026) - Bronstein, Gewirtz and Grossman, LLC, a nation
NEW YORK, June 01, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recogni
[url="]The Schall Law Firm[/url], a national shareholder rights litigation firm, reminds investors o
LOS ANGELES--(BUSINESS WIRE)---- $GOSS--GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. S
LOS ANGELES, June 01, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors th
GOSS DEADLINE ALERT: Hagens Berman Alerts Gossamer Bio (GOSS) Investors to Today's Lead Plaintiff De
SAN FRANCISCO, June 1, 2026 /PRNewswire/ -- A securities class action lawsuit has been filed against
Gossamer Bio, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Ri
LOS ANGELES, June 1, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action laws
LOS ANGELES, May 31, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights lit
SAN FRANCISCO, May 31, 2026 (GLOBE NEWSWIRE) -- A securities class action lawsuit has been filed aga
New York, New York--(Newsfile Corp. - May 31, 2026) - WHY: Rosen Law Firm, a global investor rights
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Gossamer Bio (NASDAQ:GOSS) with a
Gossamer Bio, Inc. (NASDAQ:GOSS) (the "Company"), a biopharmaceutical company focused on the
Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.20) per share which missed the analyst c
Top Wall Street analysts changed outlook on top names, downgrading ZBH, GOSS, TRI, PCG, and BOX. See
Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.21) per share which missed the analyst c
HC Wainwright & Co. analyst Patrick R. Trucchio maintains Gossamer Bio (NASDAQ:GOSS) with a B
Oppenheimer analyst Andreas Argyrides maintains Gossamer Bio (NASDAQ:GOSS) with a Outperform and
Health care sector has oversold stocks, RSI momentum indicator can help traders predict short term p
Wedbush analyst Laura Chico downgrades Gossamer Bio (NASDAQ:GOSS) from Outperform to Neutral and
Barclays analyst Eliana Merle downgrades Gossamer Bio (NASDAQ:GOSS) from Overweight to Underweigh
Leerink Partners analyst Joseph Schwartz downgrades Gossamer Bio (NASDAQ:GOSS) from Outperform to
Gossamer Bio shares plunge after Phase 3 pulmonary arterial hypertension data miss key mark, despite
- Seralutinib demonstrated a placebo-adjusted improvement in Six-Minute Walk Distance (6MWD) of +13.
Barclays analyst Eliana Merle initiates coverage on Gossamer Bio (NASDAQ:GOSS) with a Overweight
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Gossamer Bio (NASDAQ:GOSS) with a
On Thursday, 369 companies hit new 52-week lows.
On Tuesday, 647 companies set new 52-week lows.
On Tuesday, 386 stocks made new 52-week lows.